Fuji Pharma Co., Ltd. (FUP) Financial Statements
0 Followers
Fuji Pharma Co., Ltd. Financial Overview
Fuji Pharma Co., Ltd.'s market cap is currently ¥277.06M. The company's EPS TTM is ¥118.97; its P/E ratio is 15.89; and it has a dividend yield of 2.18%. Fuji Pharma Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Sep 25 | Sep 24 | Sep 23 | Sep 22 | Sep 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 51.68B | ¥ 46.14B | ¥ 40.89B | ¥ 35.43B | ¥ 33.99B |
| Gross Profit | ¥ 19.29B | ¥ 16.51B | ¥ 15.37B | ¥ 13.62B | ¥ 14.13B |
| Operating Income | ¥ 4.99B | ¥ 3.88B | ¥ 3.86B | ¥ 3.78B | ¥ 3.35B |
| EBITDA | ¥ 8.96B | ¥ 7.56B | ¥ 6.88B | ¥ 6.52B | ¥ 5.46B |
| Net Income | ¥ 3.00B | ¥ 6.15B | ¥ 3.44B | ¥ 2.70B | ¥ 2.43B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 7.25B | ¥ 4.58B | ¥ 2.32B | ¥ 3.55B | ¥ 10.20B |
| Total Assets | ¥ 93.63B | ¥ 90.58B | ¥ 86.40B | ¥ 75.97B | ¥ 64.26B |
| Total Debt | ¥ 30.94B | ¥ 29.25B | ¥ 28.95B | ¥ 24.57B | ¥ 18.66B |
| Net Debt | ¥ 23.69B | ¥ 24.67B | ¥ 26.62B | ¥ 21.02B | ¥ 8.46B |
| Total Liabilities | ¥ 46.72B | ¥ 45.01B | ¥ 45.22B | ¥ 40.17B | ¥ 31.58B |
| Stockholders' Equity | ¥ 46.91B | ¥ 45.56B | ¥ 41.17B | ¥ 35.80B | ¥ 32.68B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 3.82B | ¥ 1.37B | ¥ -1.41B | ¥ -5.75B | ¥ 2.20B |
| Operating Cash Flow | ¥ 5.80B | ¥ 4.15B | ¥ 1.92B | ¥ -658.00M | ¥ 5.99B |
| Investing Cash Flow | ¥ -4.22B | ¥ -1.66B | ¥ -5.24B | ¥ -11.27B | ¥ -2.35B |
| Financing Cash Flow | ¥ 954.00M | ¥ -435.00M | ¥ 1.92B | ¥ 5.09B | ¥ -5.43B |
Currency in JPY
